Lower inflammation marker after eight weeks.
In a controlled human trial, adults took 1,000 mg curcuminoids with piperine daily. Their average level of a blood protein that rises with inflammation fell by 33%.
See the complete Longevity researchROB’S CHOICE / THE RESEARCH
Longevity is led by 1,000 mg curcumin. Mobility is led by 100 mg boswellia extract providing 30 mg AKBA. Here are the human trials behind those amounts, plus the wider research behind the ingredients in the Daily Pair.
One Longevity.One Mobility.One daily routine.
THE LEAD HUMAN TRIALS
The two lead amounts are grounded in controlled human research. Start with the result, then open the dedicated page when you want the trial detail and wider reviews.
In a controlled human trial, adults took 1,000 mg curcuminoids with piperine daily. Their average level of a blood protein that rises with inflammation fell by 33%.
See the complete Longevity researchIn a controlled human trial, adults took 100 mg boswellia extract providing 30 mg AKBA daily. Their knee-pain scores improved by 49% compared with placebo.
See the complete Mobility researchTHE WIDER EVIDENCE
The headline findings sit within a wider body of human research.
A major review examined 103 randomized human trials of curcumin and rated the evidence for lowering this marker as high certainty.
Explore the Longevity evidenceA Cochrane review examined five boswellia studies. Its strongest comparison found that enriched boswellia improved pain and physical function.
Explore the Mobility evidenceBEYOND THE HEADLINE RESULTS
The ingredients in the Daily Pair have been studied across nine areas of health. Open any area to see the strongest findings here, without leaving the page.
Boswellia trials report less knee pain, less stiffness and better physical function.
Curcumin and boswellia studies examine soreness, strength recovery and physical performance after exercise.
Curcumin research reports lower inflammatory blood markers, while studies of both lead ingredients measure antioxidant activity.
Curcumin and boswellia research reports improved indigestion, bowel symptoms and remission measures.
Human studies report improvements in glucose control, cholesterol, liver fat and weight.
Human trials report improvements in mood, memory, attention and cognitive scores.
Human studies report improvements in nasal allergies, skin symptoms and breathing.
Human trials report improvements in PMS, period pain, bleeding duration and dialysis-related itching.
Human studies report benefits across treatment-related mouth soreness, brain swelling and a tumour-cell marker.
TWO PRIORITIES. ONE DAILY ROUTINE.
Longevity supports the years ahead with curcumin-led inflammation and antioxidant support. Mobility supports joint comfort and movement. The Daily Pair brings both into one routine.
Two Longevity capsules + One Mobility capsule · With one meal every day
R899/month · delivery included